Научно-практический журнал Медицинские технологии. Оценка и выбор
  • Русский
  • English

Medical Technologies. Assessment and Choice. № 2 | 2018 (32)

DOI: https://doi.org/10.31556/2219-0678.2018.32.2 meta

Full journal issue

 

Article Pages
NEWS DIGEST
5-7
METHODOLOGY
New Approaches to the Development of Diagnostic Related Groups for Cancer Pharmacotherapy in Russian Federation
Avxentyeva M. V., Omelyanovskiy V. V., Petrovskiy A. V., Davydov M. I., Zheleznyakova I. A., Tyulyandin S. A., Ledovskikh Yu. A., Tryakin A. A., Zuyev A. V., Fedyaev D. V., Fedyanin M. Yu., Gordeev S. S., Lazareva M. L., Semakova E. V., Kravtsov A. A.
8-23
Algorithm of Hospital Cases Classification in the Russian Model of Diagnostic Related Groups: Need for Improvement
Fedyaev D. V., Akimov O. V., Zuev A. V.
24-33
INTERNATIONAL EXPERIENCE
Health Technology Assessment in Scotland
Teptsova T. S., Lemeshko V. A.
34-41
MANAGEMENT IN HEALTH CARE
Approaches to the Definition of Specialized High-Tech Medical Care
Obukhova O. V., Brutova A. S., Dergachev A. V., Bazarova I. N.
42-47
ORIGINAL RESEARCH
Efficacy and Efficiency of Mechanical Thromboextraction in Combination with Thrombolytic Therapy or as an Independent Method of Intravascular Treatment in Patients with Ischemic Stroke
Dombrovsky V. S., Ivakhnenko O. I., Avxentyeva M. V., Omelyanovskiy V. V., Musina N. Z.
48-59
Advantages of Digital Radiography in Improving the Efficiency of Radiology Departments
Yudakova S. I., Morozov S. P., Vetsheva N. N., Kim K. A.
60-66
Pharmacoeconomic Evaluation of PD-L1 Receptor Inhibitors for the Second Line Treatment of Metastatic Non-Small Cell Lung Cancer
Avxentyev N. A., Zhuravleva M. V., Makarov A. S., Semiglazova T. Yu., Frolov M. Yu.
67-80
Pharmacoeconomic Analysis of Tiotropium Bromide and Olodaterol Fixed Combination as Maintenance Therapy in Patients with Chronic Obstructive Pulmonary Disease in Russian Federation
Nedogoda S. V., Barykina I. N., Salasyuk A. S., Smirnova V. O., Popova E. A., Zhuravleva M. V.
81-93
Pharmacoeconomic Study of the Eliquis (Apixaban) Use within the Program of Essential Medicines Provision in the Russian Federation
Derkach E. V., Boyarskaya T. V.
94-102